Is This Elon's Worst Nightmare?
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
| Open | 143.90 | Prev Close | 143.32 |
| High | 146.60 | Low | 143.16 |
| Volume | 1,218,109 | Volume (Avg) | 1,434 |
| 52 Week High | 204.18 | 52 Week Low | 110.04 |
| Market Cap | 21.1B | PE Ratio | 13.78 |
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 7,605 |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Highlights
| Analyst Target | 169.23 |
| Market Cap | 21,112,100,000 |
| PE Ratio | 13.78 |
| PEG Ratio | 6.24 |
| EBITDA | 3,222,400,000 |
Valuation
| Trailing PE | 13.87 |
| Forward PE | 9.04 |
| Price/Sales (Trailing 12 Mt.) | 2.12 |
| Price/Book (Most Recent Quarter) | 1.20 |
Technicals
| Beta | 0.12 |
| 52 Week High | 204.18 |
| 52 Week Low | 110.04 |
| 50 Day Average | 7.07% |
| 200 Day Average | 5.67% |
Earnings
Donald Trump Calls For Soros To Be Imprisoned: 'He's A Bad Guy'
President Trump has advocated for the imprisonment of billionaire Democratic donor George Soros.
Bill Ackman Has 70% Of His Portfolio Invested In These 5 Stocks: Here's What Q2 13F Filings Show
Discover how Bill Ackman invested ~70% of his $13.7M portfolio in 5 stocks like UBER & AMZN per Q2 2025 13F filings. Explore top holdings now!
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Broadcom, Lululemon, Opendoor, Docusign And Neonode: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks advanced on Thursday, with the Nasdaq Composite jumping over 200 points, or nearly 1%, to 21,707.69.
Powerball, Mega Millions Missing Jackpots: What Happens To Unclaimed Lottery Tickets
Powerball is one of the most popular lottery games that can offer hundreds of millions of dollars, or in some cases billions, in potential winnings.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Powerball Jackpot Soars To $1.1 Billion After No Winning Tickets, 5th Largest In History
The Powerball jackpot has reached $1.1 billion after no winner in Saturday's drawing, with nine tickets earning $1 million.
Trump Claims India Is Now Offering To Cut Its Tariffs To 'Nothing,' But Says It's Too Late — 'Should Have Done So Years Ago'
President Donald Trump criticized the longstanding trade dynamic between India and the United States, while signaling a potential breakthrough in trade negotiations with the South Asian country.
This Gold Miner Has the Map, the Metal, and the Momentum - Ad
JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
US media quickly forced to revisit a thorny question: How should a president's health be covered?
Early in Donald Trump's Tuesday, Fox News' Peter Doocy asked a question that surely baffled people who avoided social media for Labor Day.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.
Stock Market Today: Dow, S&P 500 Futures Slip—Adobe, Warner Bros, Super Micro In Focus
U.S. stock futures declined on Friday following Thursday's rally. Futures of major benchmark indices were lower.
Elizabeth Warren Suppprts Bipartisan Bill To Ban Individual Stock Trading By Lawmakers: 'It's About Time'
Sen. Elizabeth Warren (D-Mass.) is lauding a new bipartisan effort to ban members of Congress from trading individual stocks, calling the move long overdue.
Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad
The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.
Gen Z Happiness Levels Lower Than People Battling Mid-Life Crisis, Shows Study: Bad Mental Days Explode For The Young
Study finds young adults report lower well-being, reversing midlife unhappiness hump. Causes and cures debated as mental health strains rise.
Gold's Best Year Since 1978—What's Driving The Relentless Rally?
Gold has surged 37% in 2025, topping $3,500 an ounce. Discover what's driving the rally, from Fed politics to central bank buying.
The Roadmap to $100M+ Revenue - Ad
Recurring deals, Tier-1 banks, and expansion into new markets put this company on track to triple revenue by 2026. Yet the market cap is still just $21M.
Toyota Reshapes US Strategy: More Hybrids, New EVs, Fewer Lexus Sedans
Toyota Motor shares are trading lower on Wednesday after Reuters reported that the carmaker was adjusting its U.S. manufacturing footprint.
Mark Cuban Once Revealed His Favorite Movie Genre Is Apocalypse Chaos — He Even Digged This 'Horrible' Film
Mark Cuban once admitted he's hooked on end-of-the-world movies — even critically panned ones — a quirky obsession that explains his cameo in Sharknado 3.
Scarcity Meets Momentum - Ad
With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report
Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs.
South Korea president says Korean companies will hesitate to invest in US without better visa system
SEOUL, South Korea (AP) — South Korea’s president said Thursday that South Korean companies will likely hesitate to maintain or make direct investments in the United States if the U.S. fails to for Korean workers.
Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad
Gold has hit all-time highs, breaking $3,600 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Von der Leyen proposes bolder EU sanctions against Israel over the war in Gaza
ANTWERP, Belgium (AP) — European Commission President Ursula von der Leyen broke Wednesday with her pro-Israel stance and announced plans to seek sanctions and a partial trade suspension against Israel over .
Nvidia, CrowdStrike, Snowflake, CoreWeave, Polestar Automotive: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.3% at 45,565.23.
The $25M Contract Nobody Is Talking About - Ad
One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.
What's Happening With Regeneron Pharmaceuticals Stock On Monday?
Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the way for future development.
Trump's Nvidia Export Deal Collides With AI GAIN Act — Chipmaker Warns New Bill Could Cripple Global Competition
Nvidia warned that a new U.S. bill could hurt its global edge by restricting AI chip exports, while growing pressure pushes tech firms like OpenAI to seek alternatives.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Elon Musk's SpaceX Acquires EchoStar Spectrum To Transform Global Satellite Connectivity
EchoStar is selling AWS-4 and H-block spectrum to SpaceX for $17 billion, funding debt payments and expanding 5G services with Starlink Direct to Cell.
At TIFF, the mid-sized movie strives to survive
TORONTO (AP) — Anyone will tell you it’s the audiences that make the . They aren’t purely industry folks, like they are in Cannes or Venice, but more boisterous, enthusiastic moviegoers with their own rituals, like growling like buccaneers at the piracy warning that plays before each screening.
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Trump Will 'Take Over The Fed,' Larry Kudlow Says
Jerome Powell is the Federal Reserve Chairman until May 2026. What comes after that is anyone's guess. Economist Larry Kudlow makes his predictions.
McDonald's plans $200 million investment to promote regenerative practices on US cattle ranches
McDonald’s said Monday it plans to invest $200 million over the next seven years to promote on cattle ranches.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Lutnick Hints At Fannie Mae, Freddie Mac IPO In 2025 To Show The 'Mark To Market' Worth To American Taxpayers—'Largest IPO In History'
Commerce Secretary Howard Lutnick suggested that the U.S. government is considering a public offering for Fannie Mae and Freddie Mac, a move that could be implemented this year.
Trump Says Russian Drone Incursion Into Poland Possibly An Error: 'Could Have Been A Mistake'
Trump downplays Russian drones entering Polish airspace, implying it was unintentional. European leaders fear it was deliberate while NATO responds.
This Gold Miner Has the Map, the Metal, and the Momentum - Ad
JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.
AI Bull Market Fuels A Wave Of New Listings: 3 IPO ETFs In Focus
IPO-ETFs like IPO, FPX and FPXI are in focus as the U.S. market sees its fastest rebound since 2021, fueled by the AI boom and $23B raised year-to-date.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.